Os Therapies Incorporated Stock Market Value
| OSTX Stock | 1.36 0.00 0.00% |
| Symbol | OSTX |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OS Therapies. Anticipated expansion of OSTX directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OS Therapies assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of OS Therapies is measured differently than its book value, which is the value of OSTX that is recorded on the company's balance sheet. Investors also form their own opinion of OS Therapies' value that differs from its market value or its book value, called intrinsic value, which is OS Therapies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OS Therapies' market value can be influenced by many factors that don't directly affect OS Therapies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OS Therapies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OS Therapies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OS Therapies' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
OS Therapies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OS Therapies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OS Therapies.
| 11/27/2025 |
| 02/25/2026 |
If you would invest 0.00 in OS Therapies on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding OS Therapies Incorporated or generate 0.0% return on investment in OS Therapies over 90 days. OS Therapies is related to or competes with Spruce Biosciences, Werewolf Therapeutics, OUTLOOK THERAPEUTICS, IO Biotech, CervoMed, Mink Therapeutics, and Equillium. OS Therapies is entity of United States. It is traded as Stock on NYSE MKT exchange. More
OS Therapies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OS Therapies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OS Therapies Incorporated upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 16.39 | |||
| Value At Risk | (5.81) | |||
| Potential Upside | 5.56 |
OS Therapies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OS Therapies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OS Therapies' standard deviation. In reality, there are many statistical measures that can use OS Therapies historical prices to predict the future OS Therapies' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (0.49) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OS Therapies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
OS Therapies February 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.48) | |||
| Mean Deviation | 3.18 | |||
| Coefficient Of Variation | (895.83) | |||
| Standard Deviation | 3.9 | |||
| Variance | 15.18 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (0.49) | |||
| Maximum Drawdown | 16.39 | |||
| Value At Risk | (5.81) | |||
| Potential Upside | 5.56 | |||
| Skewness | (0.03) | |||
| Kurtosis | (0.30) |
OS Therapies Backtested Returns
OS Therapies retains Efficiency (Sharpe Ratio) of -0.0911, which implies the firm had a -0.0911 % return per unit of price deviation over the last 3 months. OS Therapies exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OS Therapies' information ratio of (0.14), and Market Risk Adjusted Performance of (0.48) to confirm the risk estimate we provide. The company owns a Beta (Systematic Risk) of 0.91, which implies possible diversification benefits within a given portfolio. OS Therapies returns are very sensitive to returns on the market. As the market goes up or down, OS Therapies is expected to follow. At this point, OS Therapies has a negative expected return of -0.38%. Please make sure to check OS Therapies' standard deviation, potential upside, day typical price, as well as the relationship between the jensen alpha and accumulation distribution , to decide if OS Therapies performance from the past will be repeated sooner or later.
Auto-correlation | 0.78 |
Good predictability
OS Therapies Incorporated has good predictability. Overlapping area represents the amount of predictability between OS Therapies time series from 27th of November 2025 to 11th of January 2026 and 11th of January 2026 to 25th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OS Therapies price movement. The serial correlation of 0.78 indicates that around 78.0% of current OS Therapies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.78 | |
| Spearman Rank Test | 0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.